Updated:
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001640455, and its reported...
Overview
Jounce Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001640455, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2023-03-10, it reported net income of USD -50,919,000; total assets of USD 212,550,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Jounce Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001640455
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2022USD | -$50.9M | $212.6M | $150.6M | -$28.9M | |
| FY2021USD | -$90.9M | $252.7M | $95.5M | -$83.5M | |
| FY2020USD | -$43.8M | $244.2M | $147.5M | -$27.8M | |
| FY2019USD | $56.8M | $205.9M | $53.2M | -$30.1M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13D | — | Form SC 13D | |
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Jounce Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.